Abstract
Objectives:
Characterize the precipitants and outcomes of psychiatric hospitalizations among patients enrolled in a comprehensive dementia care program and identify factors associated with discharge to higher-level residential setting.
Design:
Retrospective cohort study.
Setting:
UCLA Alzheimer’s and Dementia Care Program.
Participants:
Patients hospitalized at the UCLA Resnick Neuropsychiatric Hospital (NPH).
Measurements:
Precipitating reasons for hospitalization, patient demographic and clinical characteristics, hospitalization-level characteristics, and caregiver relationship. Discharge to higher-level residential settings (e.g., assisted living, nursing home). Change in scheduled Central Nervous System (CNS)-active medications (antipsychotics, antidepressants, and sedative/hypnotics).
Results:
There were 180 psychiatric hospitalizations among 150 patients, with a median age of 79 years (IQR, 73–85) at admission and MMSE score of 17 (IQR, 12–24) at first hospitalization. Agitation was the most common precipitating reason for hospitalization (n=127, 71%). Median length of stay was 14 days (IQR, 9–26); 54 (30%) resulted in discharge to a higher-level residential setting. In adjusted analyses, agitation as the precipitant for hospitalization (aOR, 4.7; 95% CI, 1.7–12.9, p=0.003) and male sex (aOR, 2.3; 95% CI, 1.0–5.5, p=0.049) were associated with higher odds of discharge to a higher-level setting. Most hospitalizations resulted in no change in the number of scheduled CNS-active medications (e.g., 69% had no change in the number of scheduled antipsychotics), while escalation occurred in 19% to 28%, depending on medication class.
Conclusion:
Psychiatric hospitalization precipitated by agitation or involving male patients was often followed by transition to higher-level residential care. Future studies should evaluate whether earlier outpatient psychiatry involvement and proactive placement planning can reduce hospitalization and subsequent placement changes.
Keywords: Psychiatric Hospitalizations, Comprehensive Dementia Care, Neuropsychiatric symptoms, Psychotropic medications
INTRODUCTION
Neuropsychiatric behavioral symptoms such as agitation, psychosis, and mood disturbances are prevalent among persons living with dementia (PLWD), affecting about 75% of PLWD.1 These symptoms can lead to caregiver distress, reduced quality of life, and increased emergency department and hospital utilization.2–5 As Alzheimer’s disease and related dementias (ADRD) progresses, behavioral symptoms often become more prominent.6 The management of behavioral symptoms in outpatient settings is often difficult because of limited access to geriatric psychiatrists, challenges in closely monitoring treatment responses, and the limited effectiveness of currently available medications. In 2018, about 40% of psychiatric hospital patients had an ADRD diagnosis.7 With over 7 million PLWD4 and only about 600 psychiatric hospitals with approximately 4,500 beds in the United States,8 understanding predictors for psychiatric hospitalization is important given limited health system capacity. Psychiatric hospitalization may also cause substantial disruption to normal care routines, contribute to caregiver burden and distress, and create uncertainty surrounding discharge disposition and long-term placement.9,10
Comprehensive dementia care programs and the Centers for Medicare & Medicaid Services (CMS) Guiding an Improved Dementia Experience (GUIDE) Model, which promotes national implementation of comprehensive dementia care,11,12 aim to support persons living with dementia (PLWD) and caregivers through coordinated and holistic care designed to improve quality. Comprehensive dementia care programs, such as the UCLA Alzheimer’s Dementia Care (ADC) program,13 provide longitudinal assessment and monitoring, caregiver education and support, care coordination, and management of neuropsychiatric behavioral symptoms.14–16 These programs use tools and strategies to stabilize symptoms in the outpatient setting17 and aim to avoid or reduce hospitalizations. However, when dementia-related symptoms become too severe to manage, psychiatric hospitalization for medication titration and behavioral trigger avoidance may be necessary. Little is known about the predictors and outcomes of psychiatric hospitalizations among PLWD already enrolled in comprehensive dementia care, including programs participating in the GUIDE Model, and understanding these factors could help dementia care programs identify PLWD at high-risk and better prepare families for post-discharge planning.
Comprehensive dementia care programs and the CMS GUIDE Model are also aligned with the “Aging in the Right Place” framework, which emphasizes supporting older adults to live in settings that best match their needs, preferences, and social circumstances over time.18–21 For PLWD, psychiatric hospitalization may reflect a need for changes in living arrangements, as acute behavioral symptoms, functional decline, and caregiver strain may precipitate transitions to higher-level residential care settings. Understanding predictors and outcomes of psychiatric hospitalization among PLWD enrolled in comprehensive dementia care programs may help identify opportunities to better support aging in the right place and reduce potentially avoidable institutional transitions.
This study examined psychiatric hospitalizations at the UCLA Resnick Neuropsychiatric Hospital (NPH) among patients enrolled in the UCLA ADC program, which uses advanced practice practitioners who longitudinally co-manage dementia-related needs and support transitions in care when needed. This study characterized the precipitants of psychiatric hospitalization, changes to residential living setting at discharge, and patterns of medication prescribing.
METHODS
Study Design and Setting
This was a retrospective cohort study of patients enrolled in the UCLA ADC Program who were hospitalized at the UCLA Resnick Neuropsychiatric Hospital, which provides expert evaluation and treatment for dementia-related symptoms and mood disorders by providing a calming environment (therapeutic milieu) with mostly private rooms, outdoor spaces, and management by psychiatrists and other support staff. This study was approved by the UCLA Institutional Review Board.
Study Sample
All UCLA ADC patients were screened for eligible hospitalizations using an electronic medical record data pull, and only admissions to the UCLA NPH were included. Among the 3,837 PLWD enrolled in the UCLA ADC program between January 1st, 2012 and May 1st, 2024, 150 ADC patients had 180 psychiatric hospitalizations and were evaluated in this study. To be a UCLA ADC Program patient, they needed to have: 1) a dementia diagnosis, 2) receive care from a partnering UCLA physician (e.g., primary care provider, psychiatrist, or neurologist), 3) have an identified caregiver, and 4) not be enrolled in hospice or permanently reside in a skilled long-term care facility.
Outcome Measures
Residential care level was categorized as home, group care living setting (board and care, memory care, or assisted living), or nursing facility. The primary outcome was change in level of residential setting at psychiatric hospital discharge, defined as discharge to a higher-level residential care setting versus return to the same or a lower-level of residential care. A secondary outcome was change in scheduled Central Nervous System (CNS)-active medication prescribing before and at discharge from the hospital, categorized as de-escalation, no change, or escalation across three medication classes: antipsychotics, antidepressants, and sedative/hypnotic medications (eTable 1 for specific medications).
Additional Measures
Additional patient-level measures included demographic characteristics (sex, race and ethnicity); caregiver relationship (spouse, adult child, or other caregiver such as a sibling, hired caregiver, or facility staff); clinical characteristics such as age at dementia onset, Mini-Mental State Examination (MMSE) score within 12 months prior to first hospitalization,22,23 and number of independent Activities of Daily Living (ADLs) and Instrumental Activities of Daily Living (IADLs) at first hospitalization.24 Dementia type was categorized as Alzheimer disease, Lewy body dementia, vascular dementia, mixed dementia, or not otherwise specified (NOS).
Pre-hospitalization variables included precipitating reasons for hospitalization (e.g., agitation, psychotic symptoms, risk of harm to self or others, anxiety or depression, insomnia, and wandering were recorded as non-mutually exclusive categories) and outpatient psychiatrist visit within one year prior to admission. Hospitalization-related variables included length of stay, primary diagnosis at hospital discharge, and treatment for urinary tract infection (UTI) during hospitalization.
Data Collection
Electronic health record encounters and notes from NPH hospitalization were reviewed and entered in Research Electronic Data Capture (REDCap, Version 12.4.19).25,26 Chart abstractors (DRL, ASE, MT, IAJ, and DBR) completed training sessions using standardized data abstraction guidelines. Any discrepancies during abstraction were reviewed collectively and discussed until consensus was reached.
Statistical Analysis
Descriptive statistics were used to summarize demographic, clinical, and hospitalization characteristics. Continuous variables were reported as medians with interquartile ranges (IQR) and compared using the Mann-Whitney U Test; and categorical variables were summarized as frequencies and percentages and compared using Fisher’s exact tests. Transitions between pre-admission and discharge living locations were summarized descriptively and visualized using an Alluvial diagram; differences in the marginal distribution of living location pre-admission and at discharge were evaluated using the Stuart–Maxwell test. Multivariable logistic regression models were used to evaluate factors associated with transition to a higher level of care (yes vs no) at discharge. Hospitalizations served as the unit of analysis. Because some individuals contributed multiple hospitalization episodes, cluster robust standard errors were estimated at the patient level using the sandwich estimator to account for within patient correlation.27 Adjusted odds ratios (aORs) and 95% confidence intervals (CIs) were derived from model coefficients and robust standard errors, using the sandwich and lmtest packages in R. Covariates were selected based on clinical judgment and include age at hospitalization (years), patient sex (female vs male), spouse as primary caregiver (yes vs no), agitation as precipitating reason for hospitalization (yes vs no), and whether the patient was evaluated by an outpatient psychiatrist within the year prior to admission (yes vs no). Of note, hospitalizations occurring within 14 days of discharge from a prior hospitalization were considered unplanned readmissions within the same clinical episode; in these instances, only the final hospitalization was retained for analysis. All tests were two-sided with statistical significance level set at P<.05. Statistical analyses were performed using R statistical software (v4.1.3).
RESULTS
Patient and Hospitalization Characteristics
There were 180 psychiatric hospitalizations among 150 patients (Table 1), with 19 patients (13%) experiencing more than one hospitalization. Among individuals with repeat hospitalizations, the median time between hospitalizations was 13.3 months (IQR, 6.0–27.7 months).
Table 1.
Demographic, Clinical, and Hospital Characteristics by Discharge to a Same or Lower vs Higher Residential Care Setting.
| Patient Demographic and Clinical Characteristics at First Hospitalization | ||||
|---|---|---|---|---|
| Total Sample (n=150) | Same or Lower Care Setting n=101 (67%) | Higher-Level Care Setting n=49 (33%) | p-valuea | |
| Men, n (%) | 45 (30%) | 26 (25.7%) | 19 (38.8%) | 0.13 |
| Race and Ethnicity | 0.3 | |||
| Non-Hispanic White | 90 (60%) | 60 (59.4%) | 30 (61.2%) | |
| Non-Hispanic Black | 11 (7%) | 6 (5.9%) | 5 (10.2%) | |
| Non-Hispanic Asian | 9 (6%) | 5 (5%) | 4 (8.2%) | |
| Hispanic or Latino | 16 (11%) | 10 (9.9%) | 6 (12.2%) | |
| Otherb | 24 (16%) | 20 (19.8%) | 4 (8.2%) | |
| Caregiver Relationship, n (%) | 0.5 | |||
| Spouse | 60 (40%) | 39 (39.8%) | 21 (42.9%) | |
| Children | 57 (38%) | 39 (39.8%) | 18 (36.7%) | |
| Other (i.e. siblings, hired caregiver/agency, facility) | 30 (20%) | 20 (18%) | 10 (19%) | |
| Median age of dementia onset (IQR), years | 74 (68 – 81) | 74 (68–81) | 75 (69–79) | 0.7 |
| Dementia Type, n (%) | 0.9 | |||
| Alzheimer’s Disease | 71 (47%) | 48 (47.5%) | 23 (46.9%) | |
| Lewy Body Dementia | 16 (11%) | 10 (9.9%) | 6 (12.2%) | |
| Vascular Dementia | 11 (7%) | 9 (8.9%) | 2 (4.1%) | |
| Mixed Dementia | 14 (9%) | 9 (8.9%) | 5 (10.2%) | |
| Dementia NOS | 38 (25%) | 25 (24.8%) | 13 (26.5%) | |
| Median MMSE Score within one year prior to first hospitalization (IQR) | 17 (12 – 24) | 17 (11–24) | 17 (12–22) | 0.7 |
| Median number of independent ADLs at first hospitalization (IQR) | 5 (2–6) | 5 (2–6) | 5 (2–6) | 0.5 |
| Median number of independent IADL at first hospitalization (IQR) | 0 (0–1) | 0 (0–1) | 0 (0–1) | 0.7 |
| Hospitalization Characteristics | ||||
|---|---|---|---|---|
| Total Sample (n=180) | Same or Lower Care Setting n=126 (70%) | Higher-Level Care Setting n=54 (30%) | p-valuea | |
| Median age (IQR), years | 79 (73 – 85) | 79 (73–85.5) | 79 (73–85) | >0.9 |
| Median Length of Stay (IQR), days | 14 (9 – 26) | 14 (8–22.8) | 15.5 (10–28.8) | 0.16 |
| Reason for going to hospital, n (%)c | ||||
| Agitation | 127 (71%) | 79 (62.7%) | 48 (88.9%) | <0.001 |
| Psychotic Symptoms | 82 (46%) | 57 (45.2%) | 25 (46.3%) | >0.9 |
| Risk of harm to self or others | 66 (37%) | 44 (34.9%) | 22 (40.7%) | 0.5 |
| Anxiety / Depression | 42 (23%) | 33 (26.2%) | 9 (16.7%) | 0.18 |
| Insomnia / Sleep Disturbances | 33 (18%) | 25 (19.8%) | 8 (14.8%) | 0.5 |
| Wandering | 24 (13%) | 18 (14.3%) | 6 (11.1%) | 0.6 |
| Primary Diagnosis at Discharge, n (%) | 0.06 | |||
| Dementia with Behavioral Disturbance | 119 (66%) | 77 (62.1%) | 42 (80.8%) | |
| Dementia and Primary Psychiatric Condition (i.e., Bipolar disorder, Schizophrenia, Substance Use Disorder, Suicidal Ideation) | 44 (24%) | 36 (29%) | 8 (15.4%) | |
| Dementia and Delirium (i.e. secondary to infection, substance use). | 13 (7%) | 11 (8.9%) | 2 (3.8%) | |
| Treated for Urinary Tract Infection during the hospitalization, n (%) | 60 (33%) | 38 (30.4%) | 22 (41.5%) | 0.17 |
| Outpatient psychiatry visit within one year prior to admission, n (%) | 72 (40%) | 55 (45.8%) | 17 (32.1%) | 0.10 |
Abbreviations – IQR: interquartile range; MMSE: Mini Mental State Examination; ADL: Activities of Daily Living; IADL: Instrumental Activities of Daily Living; NOS: Not Otherwise Specified.
Continuous variables were compared using Mann-Whitney U tests and categorical variables using Fisher’s exact tests.
“Other” includes “American Indian or Alaska Native”; “Middle Eastern or North African”; “Multiple Races”; “Other”; “Patient Refused”; “Unknown”.
Not mutually exclusive categories.
At the patient-level (n=150), 45 PLWD (30%) were men. Most PLWD were non-Hispanic White (n=90, 60%), followed by Hispanic or Latino (n=16, 11%), non-Hispanic Black (n=11, 7%), and non-Hispanic Asian (n=9, 6%). Caregivers were most commonly spouses (n=60, 40%) or adult children (n=57, 38%). The median age at dementia onset was 74 years (IQR, 68–81), and Alzheimer’s disease was the most common dementia diagnosis (n=71, 47%), followed by dementia NOS (n=38, 25%). The median MMSE score within one year prior to first hospitalization was 17 (IQR, 12–24). PLWD had a median of 5 independent ADLs (IQR, 2–6) and 0 independent IADLs (IQR, 0–1) at first hospitalization.
At the hospitalization level, the median age at admission was 79 years (IQR, 73–85), and the median length of stay was 14 days (IQR, 9–26). Agitation was the most common reason for NPH hospitalization (n=127, 71%) and Dementia with Behavioral Disturbance was the most common primary diagnosis at discharge (n=119, 66%). One third of hospitalizations involved treatment for a urinary tract infection (n=60, 33%), with documented cognitive improvement following antibiotic treatment occurring in 20 of 60 hospitalizations (33%). Only 72 hospitalizations (40%) had an outpatient psychiatry visit within one year prior to admission.
Transitions in Living Situation Pre-admission and at Discharge
There were 129 admissions (72%) originated from home, 41 (23%) from group care setting, and 10 (6%) from nursing facility (Figure 1). Among admissions originating from home, 78 (60%) were discharged home, while 51 (40%) were discharged to a higher level of care, including 33 (26%) to group care setting and 18 (14%) to nursing facility. Most admissions from group care settings returned to the same setting (37/41, 90%), while 3 (7%) were discharged to a nursing facility. Similarly, most admissions from nursing facility returned to a nursing facility (8/10, 80%). Overall, 54 (30%) hospitalizations resulted in discharged to a higher level of residential care, and agitation as the reason for hospitalization was more common among discharge to a higher level of residential care than among those discharged to the same or lower level of care (89% vs 63%, Fisher’s exact test, p<0.001) (Table 1). The distribution of living locations changed between pre-admission and discharge (Stuart–Maxwell, χ2=45.4, df=2, p<0.001), with the proportion of admissions residing in a group care setting or nursing facility increasing from 28% (n=51) pre-admission to 56% at discharge (n=100) (Figure 1).
Figure 1. Transitions in Living Location Pre-admission and at Discharge Following Neuropsychiatric Hospitalization.

The diagram shows proportions and transitions between pre-admission and discharge living locations. Flow widths are proportional to the number of individuals in each transition pathway. Group care setting refers to board and care, memory care units, and assisted living facilities. The overall distribution of living locations differed significantly between pre-admission and discharge (Stuart–Maxwell test, χ2= 45.43, df=2, p<0.001).
Multivariable Predictors of Discharge to a Higher-Level Residential Care Setting
In a multivariable logistic regression analyses of 180 hospitalization, male sex compared to female sex (aOR, 2.3; 95% CI, 1.0–5.5; p=0.049) and agitation as the reason for hospitalization (aOR, 4.7; 95% CI 1.7–12.9; p=0.003) were associated with higher odds of discharge to a higher-level residential care setting (Table 2). Patient age, spouse as primary caregiver, and having had an outpatient psychiatry visit in the year prior to hospitalization were not significantly associated with change in residential care setting. Regression models accounted for repeated hospitalizations using cluster robust standard errors at the patient level.
Table 2.
Factors Associated with Discharge to a Higher-Level Residential Care Setting.
| Covariates | Adjusted Odds Ratio (95% CI) | p-valuea |
|---|---|---|
| Patient Age (years) | 1.02 (0.98–1.06) | 0.3 |
| Patient Male sex (ref: Female) | 2.34 (1.01–5.45) | 0.049 |
| Spouse caregiver (ref: all other) | 1.27 (0.61–2.52) | 0.5 |
| Agitation as reason for going to the hospital (ref: Not Agitation) | 4.67 (1.69–12.88) | 0.003 |
| Outpatient psychiatry visit within one year prior to admission (ref: No) | 0.72 (0.35–1.50) | 0.4 |
Adjusted odds ratios, 95% confidence intervals, and P-values were estimated using a logistic regression model with robust standard errors clustered at the patient level to account for repeated hospitalizations.
Changes in CNS-Active Medication Prescribing
Across the three CNS-active medication classes, most NPH hospitalizations resulted in no change in the number of scheduled medications (Figure 2). Initiation or escalation of medications occurred in 22% of hospitalizations for antipsychotics, 28% for antidepressants, and 19% for sedative/hypnotics. De-escalation was less common, occurring in 9% of hospitalizations for antipsychotics, 16% for antidepressants, and 13% for sedative/hypnotics.
Figure 2. Change in the Number of Scheduled CNS-Active Medications (De-escalation, No Change, Escalation).

Stacked bars show the proportion of patients with de-escalation, no change, or initiation/escalation in prescribed antipsychotic, antidepressant, and sedative/hypnotic medications from before hospitalization to discharge. Medication class categories were not mutually exclusive, and patients could be included in multiple categories.
DISCUSSION
Among comprehensive dementia care program patients admitted to a psychiatric hospital, nearly one-third of hospitalizations resulted in discharge to a higher-level residential care setting. Agitation as the precipitating reason for hospitalization and male sex were associated with discharge to a higher-level care setting. About one-third of patients were treated for a UTI during admission, yet documented improvement was noted in only one-third of those treated. Fewer than half of hospitalizations were preceded by an outpatient psychiatry visit in the prior year, and scheduled psychotropics were rarely de-escalated; most patients were discharged on the same or a higher number of psychotropic medications.
Discharges to a higher-level residential care setting were frequent in our cohort, consistent with national trends in which PLWD are less often discharged home and more frequently discharged to a skilled nursing facility after inpatient psychiatric hospitalization.7 Although our study could not distinguish short-term placements (e.g., skilled nursing facilities for rehabilitation) from long-term settings (e.g., custodial nursing homes), these transitions in living situation may reflect multiple overlapping factors. First, psychiatric hospitalizations may signal worsening neuropsychiatric symptoms or functional decline related to ADRD progression.6,28,29 The hospitalization may have been precipitated by inadequate caregiving support in the pre-hospital setting as the disease progressed. Alternatively, the pre-hospital living environment may have been adequate until an acute behavioral crisis made returning to the prior living situation unsafe or unsustainable. Additionally, the hospitalization itself may have contributed to subsequent need for higher-level care through deconditioning, delirium, or further loss of functional abilities. Together, the findings underscore the importance of aligning care needs with the most supportive and sustainable living environment, consistent with the “Aging in the Right Place” framework.18–21 Future improvement efforts, including the use of social needs surveys,30 could help comprehensive dementia care programs anticipate transitions, support proactive planning, and ensure families are prepared for residential options when behavioral crises arise.
Additionally, agitation as the reason for hospitalization was strongly associated with discharge to a higher-level residential care. This is consistent with prior literature showing that dementia-related behavioral symptoms are associated with disease progression, caregiver burden, and risk of institutionalization.28,31,32 Our findings also suggest that urinary tract infections may be overstated as the primary cause of behavioral change since only one-third of patients treated for a urinary tract infection had documented symptom improvement. Male sex was also associated with greater likelihood of discharge to higher-level care, which may reflect differences in the perceived severity or manageability of agitated behaviors for caregivers.4,33 Notably, fewer than half of hospitalized patients had an outpatient psychiatry visit within the year prior to hospitalization, suggesting potential gaps in access to specialty behavioral health care for PLWD with worsening neuropsychiatric behavioral symptoms. Although outpatient psychiatric interventions may reduce hospitalizations in general psychiatric patients,34 their role in preventing psychiatric hospitalization among PLWD remains unclear. Overall, these results highlight the need for comprehensive dementia care programs that proactively address behavioral symptoms and caregiver needs, an approach emphasized by policies like the GUIDE model.12 Future studies could evaluate whether earlier outpatient psychiatry involvement or embedding a psychiatrist in comprehensive dementia care programs could reduce psychiatric hospitalizations and help PLWD remain safely in their pre-hospital living settings.
A strength of this study is the rigorous chart abstraction that enabled detailed assessment of patient, caregiver, and hospital-related characteristics. Additionally, by examining real-world patients enrolled in a comprehensive dementia care program, this study provides insights that can inform the development and improvement of other comprehensive dementia care programs.
There are several limitations to this study. First, this study was conducted at a single academic medical center, which may limit generalizability. Additionally, hospitalizations occurring at outside psychiatric facilities were not captured, although patients and caregivers were typically directed to the UCLA NPH by their dementia care specialist. Future studies linking UCLA ADC patient data with healthcare utilization claims could provide a more comprehensive view of healthcare use and outcomes. Second, despite detailed chart abstraction, certain clinical factors that may influence transitions in residential care, such as caregiver burden, home safety considerations, social support and financial constraints were not routinely available and therefore could not be evaluated. Additionally, this study included multiple univariable comparisons in Table 1, which may have increased the risk of Type I error; therefore, the findings from Table 1 should be interpreted cautiously. Nevertheless, these analyses were intended to descriptively characterize the cohort, whereas the primary analysis was based on multivariable regression modeling. Lastly, this study did not evaluate post-discharge trajectories, including whether higher-level residential care placements were temporary or permanent, or whether these transitions in care setting were associated with improved symptom management and clinical outcomes; however, future longitudinal studies could examine these outcomes.
CONCLUSIONS
Psychiatric hospitalization among patients enrolled in a comprehensive dementia care program was often followed by discharge to a higher-level residential care setting, particularly when hospitalization was precipitated by agitation and among men. These changes to living situation likely reflect a combination of ADRD progression, caregiver capacity, and potential hospitalization-related factors such as delirium and deconditioning. Future studies could evaluate whether strengthening comprehensive dementia care programs through earlier psychiatry involvement and proactive planning for residential care transition needs can reduce or delay psychiatric hospitalizations.
Supplementary Material
HIGHLIGHTS.
What is the primary question addressed by this study? What factors precipitate psychiatric hospitalizations and subsequent changes in residential care setting on discharge among persons enrolled in a comprehensive dementia care program?
What is the main finding of this study? In this retrospective study of 180 psychiatric hospitalizations, agitation was the most common precipitating reason for hospitalization with about one-third resulting in discharge to a higher-level residential setting. Agitation and male gender were significantly associated with transition to higher-level; patients were also discharged on a similar or higher number of Central Nervous System-active medications.
What is the meaning of the finding? Psychiatric hospitalizations precipitated by agitation was often followed by transition to a higher-level residential care setting, underscoring the need for more caregiver support, earlier psychiatry involvement, and proactive placement planning.
ACKNOWLEDGEMENTS
The authors acknowledge the contributions of the dementia care specialists and administrative staff of the UCLA ADC Program.
Funding/Support:
The time for Lee was provided through fellowship support from the Health Resources and Services Administration (HRSA) as part of the National Research Services Award T32 Primary Care Research Fellowship at UCLA (T32HP19001). Endo was funded by the Medical Student Training in Aging Research Program and the National Institute on Aging (T35AG026736).
Role of the Funder/Sponsor:
The funder had role in the design and conduct of this study.
Footnotes
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
Conflict of Interest Disclosures: The authors had no conflicts of interest to disclose.
DATA STATEMENT
Preliminary findings were presented in part at the 2024 American Geriatrics Society Annual meeting, conducted virtually. Available data is subject to approval and requires data use agreements; contact the study lead author.
REFERENCES
- 1.Lyketsos CG, Lopez O, Jones B, Fitzpatrick AL, Breitner J, DeKosky S. Prevalence of Neuropsychiatric Symptoms in Dementia and Mild Cognitive ImpairmentResults From the Cardiovascular Health Study. JAMA. 2002;288(12):1475–1483. doi: 10.1001/jama.288.12.1475 [DOI] [PubMed] [Google Scholar]
- 2.Tampi RR, Jeste DV. Dementia Is More Than Memory Loss: Neuropsychiatric Symptoms of Dementia and Their Nonpharmacological and Pharmacological Management. American Journal of Psychiatry. 2022;179(8):528–543. doi: 10.1176/appi.ajp.20220508 [DOI] [PubMed] [Google Scholar]
- 3.Shin IS, Carter M, Masterman D, Fairbanks L, Cummings JL. Neuropsychiatric symptoms and quality of life in Alzheimer disease. Am J Geriatr Psychiatry. Jun 2005;13(6):469–74. doi: 10.1176/appi.ajgp.13.6.469 [DOI] [PubMed] [Google Scholar]
- 4.2025 Alzheimer’s disease facts and figures. Alzheimers Dement. Apr 2025;21(4)doi: 10.1002/alz.70235 [DOI] [Google Scholar]
- 5.Davydow DS, Zivin K, Katon WJ, et al. Neuropsychiatric disorders and potentially preventable hospitalizations in a prospective cohort study of older Americans. J Gen Intern Med. Oct 2014;29(10):1362–71. doi: 10.1007/s11606-014-2916-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Lyketsos CG, Carrillo MC, Ryan JM, et al. Neuropsychiatric symptoms in Alzheimer’s disease. Alzheimers Dement. Sep 2011;7(5):532–9. doi: 10.1016/j.jalz.2011.05.2410 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Sorbero MJ, Sheng YF, Komanduri S, Liu JL. Use of Inpatient Psychiatric Facilities by Medicare Beneficiaries with Dementia. 2024:1–56. 2024/11/15. https://aspe.hhs.gov [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Shields MC, Yang Y, Busch SH. Private Equity Among US Psychiatric Hospitals. JAMA Psychiatry. Jul 1 2025;82(7):701–708. doi: 10.1001/jamapsychiatry.2025.0689 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Gaugler JE, Wall MM, Kane RL, et al. Does caregiver burden mediate the effects of behavioral disturbances on nursing home admission? Am J Geriatr Psychiatry. Jun 2011;19(6):497–506. doi: 10.1097/JGP.0b013e31820d92cc [DOI] [PubMed] [Google Scholar]
- 10.Sadak T, Foster Zdon S, Ishado E, Zaslavsky O, Borson S. Potentially preventable hospitalizations in dementia: family caregiver experiences. International Psychogeriatrics. 2017/07/01/ 2017;29(7):1201–1211. doi: 10.1017/S1041610217000217 [DOI] [PubMed] [Google Scholar]
- 11.Centers for Medicare & Medicaid Services (CMS) GUIDE Payment Methodology Paper: Including Overview of Patient Alignment. 2025. June 11, 2025. Accessed 08/21/2025. https://www.cms.gov/files/document/guide-payment-methodology-paper.pdf
- 12.Centers for Medicare & Medicaid Services (CMS) Guiding an Improved Dementia Experience (GUIDE) Model. Accessed 08/21/2025, https://www.cms.gov/priorities/innovation/innovation-models/guide
- 13.Reuben DB, Evertson LC, Wenger NS, et al. The University of California at Los Angeles Alzheimer’s and Dementia Care program for comprehensive, coordinated, patient-centered care: preliminary data. J Am Geriatr Soc. Dec 2013;61(12):2214–2218. doi: 10.1111/jgs.12562 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Liz Fowler J, PhD; Rawal Purva, PhD; Fogler Sarah, PhD; Schreiber Claire, MS; Gutermuth Leah, MPH; Saffer Tonya, MPH; Ho Sarena, MSPH; Ligus Kaleigh, PhD; Kaye Charlotte, MPH; Stinnett Magdelana, MSPH; Miescier Lynn, PhD. Guiding an Improved Dementia Experience by Clearing the Path for Comprehensive, High-Quality Dementia Care. 2024. https://www.cms.gov/blog/guiding-improved-dementiaexperience-clearing-path-comprehensive-high-quality-dementia-care [Google Scholar]
- 15.Reuben DB, Epstein-Lubow G, Super N. The Other Dementia Breakthrough—Comprehensive Dementia Care. JAMA Neurology. 2023;80(8):770. doi: 10.1001/jamaneurol.2023.1252 [DOI] [PubMed] [Google Scholar]
- 16.Haggerty KL, Epstein-Lubow G, Stoeckle RJ, et al. Applying an evidence-based approach to comprehensive dementia care under the new GUIDE model. Health Affairs Forefront. 2023; [Google Scholar]
- 17.Kales HC, Kern V, Kim HM, Blazek MC. Moving Evidence-Informed Assessment and Management of Behavioral and Psychological Symptoms of Dementia into the Real World: Training Family and Staff Caregivers in the DICE Approach. Am J Geriatr Psychiatry. Dec 2020;28(12):1248–1255. doi: 10.1016/j.jagp.2020.08.008 [DOI] [PubMed] [Google Scholar]
- 18.Rogers WA, Ramadhani WA, Harris MT. Defining Aging in Place: The Intersectionality of Space, Person, and Time. Innov Aging. 2020;4(4):igaa036. doi: 10.1093/geroni/igaa036 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Means R. Safe as houses? Ageing in place and vulnerable older people in the UK. Social Policy & Administration. 2007;41(1):65–85. [Google Scholar]
- 20.Wiles JL, Leibing A, Guberman N, Reeve J, Allen RE. The meaning of “aging in place” to older people. Gerontologist. Jun 2012;52(3):357–66. doi: 10.1093/geront/gnr098 [DOI] [PubMed] [Google Scholar]
- 21.Samsi K, Cole L, Manthorpe J. ‘The time has come’: reflections on the ‘tipping point’ in deciding on a care home move. Aging Ment Health. Sep 2022;26(9):1855–1861. doi: 10.1080/13607863.2021.1947963 [DOI] [PubMed] [Google Scholar]
- 22.Fasnacht JS, Wueest AS, Berres M, et al. Conversion between the Montreal Cognitive Assessment and the Mini-Mental Status Examination. J Am Geriatr Soc. Nov 8 2022;doi: 10.1111/jgs.18124 [DOI] [PubMed] [Google Scholar]
- 23.Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. Nov 1975;12(3):189–98. doi: 10.1016/0022-3956(75)90026-6 [DOI] [PubMed] [Google Scholar]
- 24.Katz S, Downs TD, Cash HR, Grotz RC. Progress in development of the index of ADL. Gerontologist. Spring 1970;10(1):20–30. doi: 10.1093/geront/10.1_part_1.20 [DOI] [PubMed] [Google Scholar]
- 25.Harris PA, Taylor R, Minor BL, et al. The REDCap consortium: Building an international community of software platform partners. J Biomed Inform. Jul 2019;95:103208. doi: 10.1016/j.jbi.2019.103208 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. Apr 2009;42(2):377–81. doi: 10.1016/j.jbi.2008.08.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Williams RL. A note on robust variance estimation for cluster-correlated data. Biometrics. 2000;56(2):645–646. [DOI] [PubMed] [Google Scholar]
- 28.Gaugler JE, Yu F, Krichbaum K, Wyman JF. Predictors of Nursing Home Admission for Persons with Dementia. Medical Care. 2009;47(2):191–198. doi: 10.1097/MLR.0b013e31818457ce [DOI] [PubMed] [Google Scholar]
- 29.Okura T, Plassman BL, Steffens DC, Llewellyn DJ, Potter GG, Langa KM. Prevalence of neuropsychiatric symptoms and their association with functional limitations in older adults in the United States: the aging, demographics, and memory study. J Am Geriatr Soc. Feb 2010;58(2):330–7. doi: 10.1111/j.1532-5415.2009.02680.x [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.United States. Department of H, Human S, Centers for M, Medicaid S. Accountable Health Communities Model. 2017. 2017/09/05. https://innovation.cms.gov/initiatives/ahcm
- 31.Reuben DB, Romero T, Evertson LC, Jennings LA. Overwhelmed: a Dementia Caregiver Vital Sign. J Gen Intern Med. Aug 13 2021;doi: 10.1007/s11606-021-07054-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Okura T, Langa KM. Caregiver burden and neuropsychiatric symptoms in older adults with cognitive impairment: the Aging, Demographics, and Memory Study (ADAMS). Alzheimer Dis Assoc Disord. Apr-Jun 2011;25(2):116–21. doi: 10.1097/WAD.0b013e318203f208 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Eikelboom WS, Pan M, Ossenkoppele R, et al. Sex differences in neuropsychiatric symptoms in Alzheimer’s disease dementia: a meta-analysis. Alzheimers Res Ther. Apr 4 2022;14(1):48. doi: 10.1186/s13195-022-00991-z [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Havlik JL, Ghomi RH, An N, Budhiraja P, Arzubi ER. Medicaid Costs and Outcomes for Patients Treated in an Outpatient Telepsychiatry Clinic. JAMA Network Open. 2025;8(5):e258558–e258558. doi: 10.1001/jamanetworkopen.2025.8558 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
Preliminary findings were presented in part at the 2024 American Geriatrics Society Annual meeting, conducted virtually. Available data is subject to approval and requires data use agreements; contact the study lead author.
